ClinicalTrials.govpublic full text
Anti-Proliferative Effects and Genomic Alterations of Abiraterone Acetate Compared to an Aromatase Inhibitor in Post-menopausal HR+ Operable Breast Cancer
post-menopausal er+ stage i-iiia primary operable breast cancer, post-menopausal, er+, stage i-iiia, operable, breast cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 891731
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.